Highlights Newsletter 5
This newsletter presents you the following key sessions:
1. PODCAST with dr. Courtney DiNardo about the VIALE-A study examining azacitidine in AML patients
2. Real-life characteristics and outcome of biopsy-proven post-transplant lymphoproliferative disorders after solid
organ transplantation
3. Similar safety and efficacy of azacitidine and decitabine in patients with treatment-naïve acute myeloid leukaemia
who are ineligible for intensive chemotherapy
4. Adding isatuximab to carfilzomib and dexamethasone significantly delays the disease progression of patients
with relapsed/refractory multiple myeloma
5. Pegcetacoplan superior to eculizumab in patients with paroxysmal nocturnal haemoglobinuria
